RespireRx Pharmaceuticals Inc (fka RSPI)

[ggg7ggg]

Dr. Tracy/others - Some basic questions for a "baseline":

1. What specifically is the issue with CX-717?
2. How likely is it that the dosage restriction will be lifted or significantly increased?
3. Will Organon ever disclose any results? Estimates of when? If positive, what are the ramifications to Cortex?
4. Once a high impact deal is done, what is a reasonable development timeline for a motivated big pharma licensee?
5. Why does a big pharma simply not buy this company?

Sincere thanks for answers!